Zhejiang Huakang Pharmaceutical Co.,Ltd.’s Net Profit Rose 8.1% in First Three Quarters of 2023

Zhejiang Huakang Pharmaceutical Co.,Ltd. (浙江华康药业股份有限公司) (605077.SH) reported a net profit of 275.2 million yuan in the first three quarters of 2023, up 8.1% year-on-year.

Meanwhile, the company posted 2 billion yuan in revenue, up 28.6% year-on-year.

At the end of the reporting period, it had 4.7 billion yuan in total assets and 1.9 billion yuan in total liabilities, with a liability-to-asset ratio of 40.3%.